Eyes on the Future: Optometry's Evolution in 2025

[Updated 2025]

The world of optometry has undergone a transformative journey in 2025, marked by groundbreaking advancements and a fervent commitment to enhancing eye care. From technological marvels to community collaboration, let's dive into the year's highlights that have shaped the continuously evolving landscape of optometry.

Advancements in Eye Care Technology

In the realm of optometry, technology has been propelling the field into new frontiers. Over the past several years, we have witnessed remarkable strides in diagnostic equipment, including state-of-the-art retinal imaging systems. The integration of telemedicine has further revolutionized eye care, enabling remote consultations and expanding access to patients worldwide. From handheld retinal cameras to versatile VR headsets, the portability of equipment has reached new heights. Notably, FDA approvals for Dry Eye IPL and RF therapies have added powerful tools to optometrists' arsenals, enhancing treatment options and patient outcomes.

In 2025, advanced optical coherence tomography (OCT) technology has made remarkable progress, with new community-based, technician-free devices like SightSync OCT offering high-resolution imaging (6 × 6 mm, 80,000 A-scans/s) to enhance accessibility. National Institutes of Health (NIH) researchers have also developed AI-enhanced ophthalmoscopy systems that improve image clarity eightfold, allowing clinicians to visualize individual retinal cells using standard clinical equipment. Additionally, swept-source OCT technology now enables wider-field imaging of the peripheral retina at faster acquisition speeds.

Myopia Management

The years leading up to 2025 saw a surge in interest and adoption of myopia management strategies in the United States. Optometrists embraced a wide range of options, from soft contact lenses and orthokeratology (ortho-k) to innovative approaches such as atropine drops and emerging technologies like red light therapy and specialized ophthalmic lenses. As we progress through 2025, the global momentum behind myopia management is poised to intensify, with continued innovation and a growing array of interventions. According to experts, roughly half of the global population is projected to develop nearsightedness by the year 2050, with around 10% experiencing severe cases of myopia.

A significant milestone occurred in September 2025 when the FDA authorized Essilor's Stellest eyeglass lenses —the first in the United States designed not only to correct nearsightedness in children aged 6 to 12 but also to slow its progression. Clinical trial data showed that Stellest lenses can slow myopia progression by 71% on average over 24 months compared with standard single-vision lenses. 

As reported by Myopia Profile, the 2025 International Myopia Institute (IMI) updates introduced "low hyperopic reserve" as a marker for pre-myopia, with new treatments including repeated low-level red light (RLRL) therapy, low-concentration atropine, and highly aspherical lenslet design spectacles, which show efficacy when worn 30+ hours per week.

Artificial Intelligence in Eye Care

The integration of artificial intelligence (AI) into optometry has witnessed an upward trajectory, ushering in a new era of possibilities. AI's applications are diverse, encompassing image analysis, diagnosis, and treatment planning. In 2025, we observed AI's impact in diabetic retinal imaging, OCT diagnosis, personalized treatment plans, telemedicine, and heightened screening for age-related macular degeneration (AMD). As companies leverage AI to analyze data and improve performance, the influence of this technology is set to expand further, promising transformative changes across the industry.

For example, while a survey of eye care specialists found 78% citing AI as the most transformative trend in ophthalmology, optometry has similarly embraced this trend, with the American Optometric Association (AOA) recognizing AI's expanding impact by separating it from telemedicine policy and undertaking a dedicated review of AI in optometry.

Reflecting optometry's growing integration with other medical specialties, the ENDO 2025 conference showcased the Simple Mobile AI Retina Tracker (SMART), an AI system achieving 99% accuracy in diabetic retinopathy screening. This technology expansion into endocrinology practices highlights the increasing demand for optometric expertise in managing systemic disease complications.

*Bonus Content: For more on AI in eye care, watch our recorded webinar, Q+A with Dr. Ted Leng on Exploring Al in Ophthalmology.

Pharma Advances in Eye Care

A pivotal moment in recent years was marked by the introduction of the first presbyopia drop, Vuity, and the groundbreaking Demodex Blepharitis drop. These pharmaceutical advances have forever altered the landscape of eye care, opening doors to innovative treatment modalities. Anticipate the influx of more presbyopia drops in the coming years, enriching the optometrist's toolkit and offering enhanced solutions for patients. Furthermore, the superior 36 exam continues to play a significant role in refining diagnostic approaches and ensuring personalized treatment plans.

For dry eye disease, the FDA approved Tryptyr (acoltremon ophthalmic solution) 0.003% in May 2025. It’s the first treatment to stimulate corneal nerves via the TRPM8 protein, targeting tear deficiency directly. Clinical trials showed that by day 14, up to four times more people using Tryptyr boosted their tear production compared to placebo, with effects lasting through day 90. Alcon launched Tryptyr in the United States in the third quarter of 2025.

Wearable Technology and AR Applications

Wearable eye technology has advanced significantly in 2025, with smart contact lenses and augmented reality (AR) eyewear leading the innovation wave. Contact lenses equipped with miniature sensor technology are now being applied in clinical settings for continuous intraocular pressure (IOP) monitoring in glaucoma patients, while development continues on tear-based glucose detection systems for diabetes care. 

Augmented reality glasses have entered practice environments, delivering diagnostic information via digital displays that display real-time metrics such as eye pressure and visual fatigue. These AR devices merge traditional vision correction with modern technology, incorporating navigation systems and assistive features for visually impaired users. 

Additionally, virtual reality systems have been adopted by optometry practices for comprehensive vision testing, including visual field mapping, dark adaptation evaluation, and color discrimination analysis.

To learn more about Virtual Field’s lightweight and portable virtual visual field technology, click below to schedule a demo with our team.

‍

Telemedicine Evolution

The AOA approved its latest revision of the Policy Statement on Telemedicine in Optometry in 2025, reflecting the rapid evolution from experimental use to a fully structured part of practice operations. The updated policy sharpens definitions of synchronous and asynchronous care, direct-to-patient applications, and standards of care, while reinforcing that mobile vision apps cannot replace comprehensive in-person eye exams. 

The policy addresses real-time patient connections, remote monitoring of chronic conditions, and new platforms supporting care delivery, with sections covering key terminology, quality criteria, training, doctor-patient relationships, use cases, and administrative considerations.

Community of ODs Coming Together

In the digital age, online communities are a vital force in optometry. These platforms serve as dynamic hubs for optometrists across the nation to collaborate, network, educate, and advocate for their profession. Providing real-time updates on breaking news in eye care, these communities offer an authentic perspective on diverse topics within the industry. In a world where connectivity is paramount, these platforms have become invaluable tools for fostering a sense of community and shared knowledge among optometrists.

Looking Ahead

As we continue through 2025, the year's achievements lay a strong foundation for the future of optometry. Optometrists anticipate further developments, including new treatments for diabetic retinopathy and macular degeneration, continued adoption of light therapy for various conditions, enhanced AI-powered retinal screening tools, and strengthened comanagement relationships with ophthalmologists to provide comprehensive patient care. From cutting-edge technology to community collaboration, these trends and advancements pave the way for an even more exciting and innovative journey ahead.